CDK9-IN-32
CDK9-IN-32 (compound 006-3) is a CDK9 inhibitor[1].
Product Specifications
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk9-in-32.html
Solubility
10 mM in DMSO
Smiles
O=C1C=C(CSC2=NN=NN2C3=CC=CC=C3)N=C4NC(NC5=CC=CC(C)=C5)=NCN41
Molecular Formula
C21H19N9OS
Molecular Weight
445.50
References & Citations
[1]Wang S, et al. Potent inhibitors targeting cyclin-dependent kinase 9 discovered via virtual high-throughput screening and absolute binding free energy calculations. Phys Chem Chem Phys. 2024 Feb 7;26 (6) :5377-5386.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK9
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV670858 1.0 µg DNA
AGTRAP Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details PC1003494-01 100 mg
(R) -5-Fluoro-2- (pyrrolidin-2-yl) pyridine dihydrochloride
Sign In for Pricing
View Details PC1003494-02 250 mg
(R) -5-Fluoro-2- (pyrrolidin-2-yl) pyridine dihydrochloride
Sign In for Pricing
View Details 
orb2906848-01 20 µg
Recombinant Novosphingobium aromaticivorans Protoheme IX farnesyltransferase (ctaB)
Sign In for Pricing
View Details orb2906848-02 100 µg
Recombinant Novosphingobium aromaticivorans Protoheme IX farnesyltransferase (ctaB)
Sign In for Pricing
View Details